1. Biosimilars in Oncology: Latest Trends and Regulatory Status
   Deeksha Joshi et al, 2022, Pharmaceutics CrossRef
2. Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imaging
   Xinggang Yang et al, 2014, Nanomedicine CrossRef
3. How long is too long: the safe use of maintenance bevacizumab in advanced-stage NSCLC
   Satya Das et al, 2015, Lung Cancer Management CrossRef